Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Inglês | IMSEAR | ID: sea-135766

RESUMO

Background & objectives: The research on the association of metabolic syndrome (MS) and substance abuse is scanty. The present research aimed to study the prevalence and correlates of MS among the inpatients at a Drug De-addiction Centre in north India. Methods: Consecutive male subjects (N=110) admitted to a drug de-addiction centre during July to December 2009 with a primary diagnosis of alcohol or opioid dependence were evaluated for the presence of MS as per the International Diabetes Federation (IDF) criteria. Results: The prevalence of MS was 24.6 and 29.3 per cent in alcohol and opioid dependent groups, respectively. MS showed a significant association with the age and body mass index (BMI) in the opioid dependent group. Co-morbid tobacco use was not associated with MS in either group. Interpretation & conclusions: The prevalence of MS in our sample of alcohol and opioid dependent male inpatients was greater than the prevalence of MS in general population, however it was comparable to that reported in physical and other psychiatric disorder populations. Even though the absence of any comparative study limits the generalizability of our findings, results indicate towards a need for screening of the patients with substance dependence especially for those aged above 30 years and/or having a high BMI for MS.


Assuntos
Fatores Etários , Alcoolismo/complicações , Índice de Massa Corporal , Humanos , Índia/epidemiologia , Pacientes Internados , Masculino , Síndrome Metabólica/epidemiologia , Síndrome Metabólica/etiologia , Transtornos Relacionados ao Uso de Opioides/complicações , Prevalência , Análise de Regressão
2.
Artigo em Inglês | IMSEAR | ID: sea-135702

RESUMO

'Club drugs’ which include Ecstasy, gamma-hydroxybutyrate (GHB), ketamine, and Rohypnol (flunitrazepam) have become popular with participants in ‘raves’, because they are perceived to enhance energy, endurance, sociability and sexual arousal. These drugs vary in their pharmacologic properties, physiological and psychological effects, and potential consequences. The use of club drugs by young people has increased in the last decade, and continue to get modified and evolve, making them very difficult to monitor. Further, these drugs are not picked up by routine drugs screening procedures, thereby making these popular with the criminals. India, which is in a phase of social transition, also faces this rising menace. Despite the nature and extent of this problem, this area has been under-researched. Data from India are sparse barring a few newspaper and police reports. Keeping abreast of current trends in club drug use prepares the clinician to recognize the clinical effects of club drug use, to manage club drug related emergencies, and to generate social awareness.


Assuntos
Anestésicos Dissociativos/efeitos adversos , Ansiolíticos/efeitos adversos , Drogas Desenhadas/efeitos adversos , Flunitrazepam/efeitos adversos , Alucinógenos/efeitos adversos , Humanos , Índia , Ketamina/efeitos adversos , N-Metil-3,4-Metilenodioxianfetamina/efeitos adversos , Psicotrópicos/efeitos adversos , Comportamento Social , Drogas Ilícitas/efeitos adversos , Transtornos Relacionados ao Uso de Substâncias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA